Declaring a dietary supplement on the Compl’Alim tele-service does not mean that its safety has been validated by the authorities. Inspections and sampling occur after the product is on the market, placing the responsibility for health compliance directly on the manufacturing laboratory. The question then becomes: what mechanisms does a dietary supplement laboratory put in place to ensure product safety before it reaches the consumer?
Analytical Control Plan: What Standard Panels Do Not Detect
Most laboratories apply a baseline of common analyses for each batch: testing for heavy metals, measuring active ingredients, microbiological control. This uniform panel is reassuring, but it has a flaw. Relevant dangers depend on the ingredients used and their geographical origin.
A plant extract imported from Southeast Asia does not present the same contamination risks as Scandinavian fish oil or a mineral sourced from a European mine. A control plan that does not take into account the raw material and the manufacturing process may overlook specific pesticide residues, extraction solvents, or mycotoxins unique to certain supply chains.
A reliable laboratory therefore adapts its analyses batch by batch. It identifies probable contaminants based on the supply chain, rather than a generic grid. To ensure the safety of products with Cydlab, this adaptive control logic is highlighted as a quality lever superior to mere regulatory compliance.
The table below compares the two approaches to illustrate the concrete differences.
| Criteria | Standard Analysis Panel | Adapted Control Plan |
|---|---|---|
| Contaminants Searched | Fixed list (heavy metals, microorganisms) | Variable list based on raw material and origin |
| Pesticide Residues | Generic panel, often limited | Targeting molecules used in the country of origin |
| Extraction Solvents | Rarely searched | Searched if the process justifies it |
| Update Frequency | Annual or less | With each change of supplier or raw material batch |
| Cost per Batch | Lower | Higher, but reduces the risk of product recall |
Nutrivigilance and Reporting of Adverse Effects: An Underestimated Post-Market Indicator
The analytical compliance of a batch does not close the question of safety. Anses collects reports of adverse effects related to dietary supplements through its nutrivigilance system. These usage feedbacks provide a signal that laboratory analyses alone do not capture.
A recent example illustrates this reality: weight loss supplements containing Garcinia cambogia were suspended in April 2025 after liver damage was reported by consumers. The affected batches may have been analytically compliant while posing a safety issue in use.
For a dietary supplement laboratory, integrating nutrivigilance into its quality approach means going beyond the certificate of analysis. It involves actively monitoring reports published by Anses, cross-referencing this data with its own formulations, and adjusting its dosages or sources of ingredients when alerts emerge.
Difference Between Regulatory Compliance and Real Safety
The declaration on Compl’Alim does not constitute a health validation. It records the existence of the product and verifies the declared composition, but no authority tests the product before its marketing. Controls by the DGCCRF occur later, by sampling.
This time lag means that a non-compliant product can remain on sale for weeks or months before being identified. Documenting the controls of each batch before marketing then becomes the only real safety net, independent of the inspection schedule.
Ingredient Traceability and Dietary Supplement Laboratory: Concrete Checks
Traceability is a term frequently highlighted by manufacturers. In practice, its level of detail varies significantly from one laboratory to another. Here are the elements that distinguish operational traceability from declarative traceability:
- Identification of the supplier of each raw material with a certificate of origin, and not just the name of the intermediary distributor. A rigorous laboratory traces back to the producer or extractor.
- Retention of samples from each batch of raw material (sample library), allowing for counter-analysis in case of post-market reporting or product recall.
- Recording of storage and transport conditions, as certain degradations (oxidation of omega-3, development of mold on dry extracts) occur between receipt and encapsulation.
- Documented link between the batch number of the finished product and the batch numbers of each ingredient used, allowing for traceability back through the supply chain within hours in case of an alert.
A laboratory that cannot link a finished product to its raw materials in less than 24 hours does not have mastery over its traceability, regardless of the number of certifications displayed.
ISO 22000 and HACCP Certifications: What They Cover and What They Do Not Cover
The ISO 22000 and HACCP standards are often presented as absolute guarantees. They certify that the laboratory has identified the hazards related to its processes and implemented control measures. However, their scope remains defined by the laboratory itself during the audit.
A laboratory certified ISO 22000 for the manufacture of vitamin capsules is not automatically certified for its plant extracts or probiotics. The consumer or healthcare professional checking a certification must look at the exact scope covered by the certificate, not just the logo.
HACCP, on the other hand, is a method, not a label. Every food manufacturer in France must apply HACCP – it is a legal obligation, not a competitive advantage. Its mention on packaging signals minimal regulatory compliance, nothing more.
The real differentiator lies in the rigor of application: frequency of internal audits, qualification of personnel trained in risk analysis, and the ability to update the HACCP plan when new ingredients or suppliers enter the production chain.
The safety of a dietary supplement is not indicated by a logo or an administrative declaration. It is built into the documentation of each batch, the adaptation of analyses to real risks, and the continuous monitoring of reports after market launch. These three pillars, combined, separate laboratories that guarantee safety from those that merely declare it.
